How to Choose a Wholesale Peptide Supplier: 12 Checks for Clinics
Use twelve evidence-based purchasing checks to compare clinic suppliers, from source verification and lot records to shipping terms and recall readiness.
For facility-specific purchasing requirements, visit our medical clinics sourcing guide. This article covers procurement, not treatment protocols.
1. Identify the supplying entity
Get the legal name and address of the actual manufacturer or compounder, not just the seller. Record which entity invoices, ships, and handles quality complaints. A distributor relationship does not replace verification of the underlying source.
2. Verify licenses and registration
Check applicable licenses with the issuing authority and confirm any claimed outsourcing-facility registration with FDA. Match the address and entity to your paperwork. Registration is not product approval or a guarantee of compliance.
3. Establish the product pathway
Have a qualified reviewer confirm the exact preparation’s eligibility, intended use, and destination-state requirements. Do not assume that a clinic account or a 503B label makes every peptide available.
4. Write an exact specification
Identify ingredient, formulation, concentration, package size, labeling, and storage requirements. Require approval before substitutions. A product nickname is not a purchase specification.
5. Review lot-specific evidence
Request representative documentation during qualification and applicable lot records before releasing an actual shipment. Match lot numbers and methods; distinguish ingredient testing from finished-product testing.
6. Separate purity from other quality attributes
A high HPLC area percentage does not establish identity, strength, sterility, or endotoxin suitability. Ask which tests apply to the preparation and who reviews the results.
7. Confirm usable shelf life
Ask how much time remains on delivery and distinguish expiration from beyond-use dating. Compare it with your expected consumption rather than assuming an unopened vial has a standard life.
8. Review shipping conditions
Confirm labeled transport conditions, monitoring evidence where required, delivery scheduling, and an escalation route for delays. A cold pack alone is not evidence of controlled transport.
9. Price the whole order
Request minimum quantities, packaging units, shipping charges, payment terms, and any fees in writing. Compare delivered cost and expected wastage, not only the advertised unit price.
10. Document exception handling
Ask how shortages, missing documents, damaged packages, and rejected deliveries are resolved. Record notification deadlines and return authorization requirements before ordering.
11. Verify recall readiness
Identify a quality contact and the process for tracing affected lots. The clinic should be able to find remaining inventory and relevant internal records promptly without relying on the sales representative’s memory.
12. Approve and periodically reassess
Store the evidence, reviewer, decision, and review date in an approved-supplier file. Reassess when the source, formulation, documentation, or regulatory position changes. A low price should not override an unresolved safety or eligibility issue.
What to do next
Record unresolved questions and the evidence your clinical or quality reviewer needs before ordering. Use the medical clinics purchasing page to prepare a facility-specific inquiry. Product mentions do not confirm stock, a legal supply pathway, or suitability for patient care.
Regulatory sources and purchasing limits
Compounded drugs are not FDA-approved. Facility registration does not establish approval or eligibility for every preparation. Verify the exact product, source, applicable federal requirements, and state rules before ordering. This is procurement education, not medical or legal advice.
- FDA: bulk substances used under section 503B, including restrictions and interim policies.
- FDA: GLP-1 compounding and shortage updates.
- FDA: safety concerns for certain compounding substances.